C Difficile
Periodontal bacteria influence systemic diseases through the gut microbiota - PubMed
Many systemic diseases, including Alzheimer disease (AD), diabetes mellitus (DM) and cardiovascular disease, are associated with microbiota dysbiosis. The oral and intestinal microbiota are directly connected anatomically, and communicate with each other through the oral-gut microbiome axis to estab …
Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE-/- mouse model of chronic apical periodontitis-induced atherosclerosis - PubMed
The study confirms the role of gut microbiota disruption in CAP-mediated atherosclerosis development, independent of serum lipid or TMAO levels. Alterations in gut microbiota composition, particularly increased Firmicutes to Bacteroidetes ratio and specific bacterial families, were associated with a …
Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE-/- mouse model of chronic apical periodontitis-induced atherosclerosis - PubMed
The study confirms the role of gut microbiota disruption in CAP-mediated atherosclerosis development, independent of serum lipid or TMAO levels. Alterations in gut microbiota composition, particularly increased Firmicutes to Bacteroidetes ratio and specific bacterial families, were associated with a …
Microbiome-based therapeutics for ocular diseases - PubMed
The relationship between the gut microbiome and ocular health has garnered increasing attention within the scientific community. Recent research has focused on the gut-eye axis, examining whether imbalances within the gut microbiome can influence the development, progression and severity of ocular d …
Suppressed oncogenic molecules involved in the treatment of colorectal cancer by fecal microbiota transplantation - PubMed
Dysbiosis of the intestinal microbiota is prevalent among patients with colorectal cancer (CRC). This study aims to explore the anticancer roles of the fecal microbiota in inhibiting the progression of colorectal cancer and possible mechanisms. The intestinal microbial dysbiosis in CRC mice was sign …
Comprehensive effects of fecal microbiota transplantation on cynomolgus macaques across various fecal conditions - PubMed
Fecal microbiota transplantation (FMT) and probiotics therapies represent key clinical options, yet their complex effects on the host are not fully understood. We evaluated the comprehensive effects of FMT using diarrheal or normal feces, as well as probiotic therapies, on multiple anatomical sites …
Clostridioides difficile hypervirulent strain ST1 isolated from clinical stool specimens obtained from three Provinces in South Africa - PubMed
The study reported for the first time hypervirulent strains ST1 in Africa and ST11 in South Africa, with a minimum spanning tree indicating an ongoing ST1 outbreak.
Clostridium Difficile Infections Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration and Companies by DelveInsight
Albany United States As per DelveInsight s assessment globally Clostridium Difficile Infections pipeline constitutes 20 key companies continuously working towards developing 22 Clostridium Difficile Infections treatment therapies analysis of Clinical Trials Therapies Mechanism of Action Route of Administration and Developments ...
Researchers in the USA investigated an mRNA-lipid nanoparticle (LNP) vaccine platform to prevent Clostridioides difficile infection and disease
Researchers in the USA investigated an mRNA-lipid nanoparticle (LNP) vaccine platform to prevent Clostridioides difficile infection and disease. The vaccine constructs contained TcdA, TcdB, and PPEP-1 sequences that were well conserved across genetically diverse strains of C difficile. In mice, a bivalent (TcdA–TcdB) or trivalent (TcdA–TcdB–PPEP-1) vaccine elicited IgG responses that were two to four times higher than those elicited by a trivalent recombinant protein vaccine with alum adjuvant. All mice immunised with monovalent TcdA or TcdB mRNA-LNP vaccines survived lethal challenge with C difficile toxins, whereas those vaccinated with recombinant TcdA or TcdB died within 1 day of challenge.
Fecal Transplant Therapy Market Advancements Highlighted by Growth, Demand, Key Drivers, Forecast To 2033
Global fecal transplant therapy market size is expected to reach $2.56 billion by 2028 at a rate of 6.1%, segmented as by procedure, fecal enema, fecal bacteriotherapy, stool transplant, human probiotic infusion, fecal transfusion
The N-terminus of the Clostridioides difficile transferase A component directs toxin activity and potency - PubMed
Clostridioides difficile infection is the leading cause of antibiotic-associated, hospital-acquired diarrhea in the USA; the pathology of which is mediated by toxins. The presence of a toxin known as the C. difficile Transferase (CDT) in some clinical isolates is linked to severe sympt …
Comparison of the STANDARD M10 C. difficile, Xpert C. difficile, and BD MAX Cdiff assays as confirmatory tests in a two-step algorithm for diagnosing Clostridioides difficile infection - PubMed
Current guidelines recommend a two-step algorithm rather than relying solely on a single test for diagnosing Clostridioides difficile infection. This algorithm starts with enzyme immunoassay (EIA) for detecting glutamate dehydrogenase (GDH) and toxins A/B, followed by nucleic acid amplificati …
Comparison of Anaerobic Culture Methods for Detecting Clostridioides difficile in Bovine Faeces - PubMed
The detection of C. difficile in a much high number of these samples by shotgun metagenomics, albeit at low levels of relative abundance, suggests that neither of these culture protocols is sensitive when levels of abundance are low.
Protection against Clostridioides difficile disease by a naturally avirulent strain - PubMed
Clostridioides difficile is a leading cause of healthcare infections. Gut dysbiosis promotes C. difficile infection (CDI) and CDIs promote gut dysbiosis, leading to frequent CDI recurrence. Although therapies preventing recurrent CDI have been developed, including live biotherapeutic products, exist …
The impact of the COVID-19 pandemic on hospital-acquired infections and multi-drug resistant organisms, in comparison to seasonal influenza - PubMed
In the COVID-19 era, HAIs and MDROs rates significantly declined, while CRE rates increased, possibly due to a national trend in Israel since 2016. Steady HHC rates suggest additional factors like enhanced environmental cleaning, personal protective equipment usage, and increased infection preventio …
Gut microbiota markers in early childhood are linked to farm living, pets in household and allergy - PubMed
Our findings indicate that lower rates of allergy in children growing up on farms or with pets may be related to early establishment of typical anaerobic commensals in their gut microbiota. However, further studies are needed to validate our observations in this small birth cohort study.
Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infection - PubMed
ERV may be useful as a potential adjunctive therapy for severe or fulminant CDI. Patients receiving ERV often were immunocompromised and had fulminant disease with critical illness. Future comparative studies are needed to evaluate the impact of adjunctive ERV for CDI.
Clostridium difficile Bacteremia in an Elderly Patient with Multiple Comorbidities: A Case Report - PubMed
Clostridium difficile (C. difficile) stands as a primary cause of health-care-associated colitis in adults; however, extraintestinal manifestations of C. difficile, particularly bacteremia, are exceptionally rare. In this report, we document a case of an elderly male with multip …
IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity - PubMed
Clostridioides difficile infection (CDI) recurs in one of five patients. Monoclonal antibodies targeting the virulence factor TcdB reduce disease recurrence, suggesting that an inadequate anti-TcdB response to CDI leads to recurrence. In patients with CDI, we discovered that IL-33 measured at diagno …
Patient Satisfaction Scale Following a Laxative for Antibiotic Washout Prior to Oral Microbiome Therapy - PubMed
AWPSS is a valid and reliable 6-item patient-reported outcome measure for use in patients requiring a laxative prior to oral microbiome therapy. AWPSS showed antibiotic washout was well tolerated and predicted that patients would be willing to consume the laxative in the future if needed.
The Lingering Shadow: Unpacking Long COVID | Health
Around 5-10% of COVID-19 sufferers experience long-term symptoms, known as long COVID. Research suggests persistent virus in the body may be a primary cause. Scientists call for trials of antivirals and innovative treatments to address long COVID, urging increased awareness and preventive measures.
The Use of Cefiderocol in Gram-Negative Bacterial Infections at International Medical Center, Jeddah, Saudi Arabia - PubMed
The results of this study support cefiderocol as a viable alternative for managing serious infections instigated by multidrug-resistant Gram-negative bacteria.
High-Resolution Melting PCR as a Fast and Simple Molecular Biology-Based Method for the Identification of Hypervirulent Clostridioides difficile Strains Directly in Stool Samples - PubMed
Clostridioides difficile became one of the main causes of nosocomial infections in all clinical settings worldwide, especially among patients undergoing antibiotic therapy. The incidence and severity of C. difficile infections, from mild diarrhea to life-threatening pseudomembranous co …
Efficacy of UV-C 254 nm Light and a Sporicidal Surface Disinfectant in Inactivating Spores from Clostridioides difficile Ribotypes In Vitro - PubMed
Clostridioides difficile is widely recognised as one of the most common causes of healthcare-associated C. difficile infections due to the ability of spores to survive for prolonged periods in the hospital environment. This study aimed to evaluate the efficacy of UV-C 254 nm light in t …